Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of Nelfinavir and Chemoradiation for Pancreatic Cancer

This study has been terminated.
(Toxicities, lack of funding)
Sponsor:
Collaborator:
Holden Comprehensive Cancer Center
Information provided by (Responsible Party):
Allen, Bryan G, University of Iowa
ClinicalTrials.gov Identifier:
NCT01086332
First received: March 11, 2010
Last updated: October 24, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2016
  Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)